CompletedNot Applicable

Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in Egypt

Egypt82 participantsStarted 2012-11

Plain-language summary

This randomized controlled community-based trial will assess the effectiveness of administration of 800 mcg sublingual misoprostol with standard of care vs. placebo with standard of care for postpartum hemorrhage treatment at the community level, primarily home births attended by primary health care unit (PHU) staff in Etay El Barood and Kafr El Dawar districts (El Beheira governorate), Egypt. Standard of care per national guidelines in this setting is referral to a higher level health facility.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * women delivering with provider from participating primary health unit (PHU) * willing and able to give informed consent * vaginal delivery Exclusion Criteria: * women too advanced into active labor to provide informed consent * known allergy to misoprostol and/or other prostaglandin * women presenting with pregnancy complications, such as hypertension, suspected multiple pregnancy, previous caesarean section, suspected still birth, antepartum hemorrhage, previous complication in the third trimester (should be referred to higher level care for delivery)

What they're measuring

Change in hemoglobin measurement of >2 g/dL pre- to -post-delivery.

Timeframe: Before delivery (at onset of labor), after delivery (2 to 4 days after delivery)

Trial details

NCT IDNCT01619072

SponsorGynuity Health Projects

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-10

View on ClinicalTrials.gov More Postpartum Hemorrhage trials